Inhibitory effect of (-)-epigallocatechin and (-)-epigallocatechin gallate against heregulin //1-induced migration/invasion of the mcf-7 breast carcinoma cell line

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 5, 2009, Pages 899-904

  Kushima, Yukihiro ^a   Iida, Kazuki ^a   Nagaoka, Yasuo ^a   Kawaratani, Yasuyuki ^a   Shirahama, Tatsuya ^a   Sakaguchi, Minoru ^b   Baba, Kimiye ^b   Hara, Yukihiko ^c   Uesato, Shinichi ^a  

^a KANSAI UNIVERSITY   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

^c Mitsui Norin Co Ltd ^*  (Japan)

Author keywords

( ) epigallocatechin; ( ) epigallocatechin 3 gallate; Heregulin j1; MCF 7; Migration invasion

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; HEREGULIN BETA 1; NEU DIFFERENTIATION FACTOR; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CANCER INVASION; CARCINOMA CELL; CELL CYCLE PHASE; CELL STRAIN MCF 7; CELL VIABILITY; CONTROLLED STUDY; CYTOSKELETON; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; METASTASIS; MIGRATION INHIBITION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CATECHIN; CELL CYCLE; CELL LINE, TUMOR; CELL MIGRATION ASSAYS; CELL MOVEMENT; CELL SURVIVAL; FEMALE; HUMANS; NEOPLASM INVASIVENESS; NEUREGULIN-1; PHOSPHORYLATION; PROTEIN MULTIMERIZATION; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3;

EID: 66749093527     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.899     Document Type: Article

References (29)

1. Guillory J. A., J. Women Aging, 6, 151-164 (1994).
2. Ciatto S., Pacini P., Azzini V, Neri A., Jannini A., Gosso P., Molino A., Capelli M. C., Di Costanzo F., Pucciatti M. A., Andreoli C., San- toro G., Farante G., Ciurli M., Costa A., Brignone G., Ravaioli A., Scarpellini M., Rosetti P., De Leo G., Punzo C., Oliva V, Cancer, 61, 1038-1040 (1988).
3. Talukder A. H., Adam L., Raz A., Kumar R., Cancer Res., 60, 474-480 (2000).
4. Menendez J. A., Mehmi I., Griggs D. W., Lupu R., Endocr. Relat. Cancer, 10, 141-152 (2003).
5. Alroy L., Yarden Y., FEBSLett., 410, 83-86 (1997).
6. Pinkas-Kramarski R., Soussan L., Waterman H., Levkowitz G., Alroy I., Klapper L., Lavi S., Seger R., Ratzkin B. J., Sela M., Yarden Y., EMBO J., 15, 2452-2467 (1996).
7. Chausovsky A., Waterman H., Elbaum M., Yarden Y., Geiger B., Ber- shadsky A. D., Oncogene, 19, 878-888 (2000).
8. Adam L., Vadlamudi R., Kondapaka S. B., Chernoff J., Mendelsohn J., Kumar R., J Biol. Chem., 273, 28238-28246 (1998).
9. Fujita Y., Yamane T., Tanaka M., Kuwata K., Okuzumi J., Takahashi T., Fujiki H., Okuda T., Jpn. J. Cancer Res., 80, 503-505 (1989).
10. Yamane T., Takahashi T., Kuwata K., Oya K., Inagake M., Kitao Y., Suganuma M., Fujiki H., Cancer Res., 55, 2081-2084 (1995).
11. Dong Z., Ma W., Huang C., Yang C. S., Cancer Res., 57, 4414-1419 (1997).
12. Suganuma M., Okabe S., Oniyama M., Tada Y., Ito H., Fujiki H., Carcinogenesis, 19, 1771-1776 (1998).
13. Lu Y. P., Lou Y. R., Xie J. G., Peng Q. Y., Liao J., Yang C. S., Huang M. T., Conney A. H., Proc. Natl. Acad. Sci. U.S.A., 99, 12455-12460 (2002).
14. Park O. J., Surh Y. J., Toxicology Lett., 150, 43-56 (2004).
15. Cao Y., Cao R., Nature (London), 398, 381 (1999).
16. Jung Y. D., Ellis L. M., Int. J. Exp. Pathol., 82, 309-316 (2001).
17. Khan N., Afaq F., Saleem M., Ahmad N., Mukhtar H., Cancer Res., 66, 2500-2505 (2006).
18. Shankar S., Ganapathy S., Srivastava R. K., Front. Biosci., 12, 4881-4899 (2007).
19. Pan M. H., Lin C. C., Lin J. K., Chen W. J., J. Agric. Food Chem., 55, 5030-5037 (2007).
20. Valcic S., Timmermann B. N., Alberts D. S., Wachter G. A., Krutzsch M., Wymer J., Guillen J. M., Anticancer Drugs, 7, 461-468 (1996).
21. Vergote D., Cren-Olive C., Chopin V, Toillon R. A., Rolando C., Hon- dermarck H., Bourhis X. L., Breast Cancer Res. Treat., 76, 195-201 (2002).
22. Albini A., Path. Oncol. Res., 4, 230-241 (1998).
23. Xue C., Liang F., Mahmood R., Vuolo M., Wyckoff J., Qian H., Tsai K. L., Kim M., Locker J., Zhang Z. Y., Segall J. E., Cancer Res., 66, 1418-1426 (2006).
24. Atlas E., Cardillo M., Mehmi I., Zahedkargaran H., Tang C., Lupu R., Mol. Cancer Res., 1, 165-175 (2003).
25. Wallasch C., Weiss F. U., Niederfellner G., Jallal B., Issing W., Ullrich A., EMBO J., 14, 4267-1275 (1995).
26. Prigent S. A., Gullick W. J., EMBO J., 13, 2831-2841 (1994).
27. Inaba H., Nagaoka Y., Kushima Y., Kumagai A., Matsumoto Y., Saka- guchi M., Baba K., Uesato S., Biol. Pharm. Bull., 31, 79-84 (2008).
28. Wells A., Marti U., Nat. Rev. Mol. Cell Biol., 3, 697-702 (2002).
29. Carpenter G., Curr. Opin. Cell Biol., 15, 143-148 (2003).